TXMD Archived Articles
TherapeuticsMD (TXMD): Navigating the Shift to a Royalty-Based Business Model
Published on March 12, 2025
TherapeuticsMD (TXMD): A Pharmaceutical Royalty Company Navigating the Changing Landscape
Published on November 30, 2024
TherapeuticsMD, Inc. (NASDAQ:TXMD): A Pharmaceutical Royalty Company Navigating a Transformative Transition
Published on September 24, 2024